Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
به نام او Role of imaging in LABC management Maryam Rahmani MD Associate professor Tehran university of Medical Science Radiology Department Imam Khomeini Hospital Imaging & LABC Diagnosis and staging Metastatic work up Response to therapy Definition T3, T4 N2 Inflammatory carcinoma Patients with LABC have a high risk of both LR and DM. Proper initial imaging of the breast and nodal beds is essential for staging, determining response to neoadjuvant therapy, and RT planning. Breast conservation can be achieved in a select population of patients who have noninflammatory LABC and a good response to neoadjuvant chemotherapy. Role of imaging Local staging; mammography US MRI Metastatic work up Response to neoadjuant therapy;MRI Case 1 & 2 CNB proved IDC Dense breast in mammography Multiple masses in US Metastatic work up ;negative MRI performed for initial local staging Case 1 Bulky tumor Skin;nl Nipple;nl Pectoralis muscle;nl LN;N1 Maybe a good candidate for breast conserving surgery Marker replacement before NAC The consensus reached at the Canadian Consortium for Locally Advanced Breast Cancer (COLAB) in 2011 was that clips should be inserted at the time of diagnosis to mark tumor location and that should be considered the standard of care. Ontario Use of clips allows for more accurate identification of the original tumor site (especially if there is complete response), resection of all (previously) cancerous tissue with adequate margins, pathologic interpretation of the most appropriate area of specimens, and greater accuracy of molecular analyses. Case 2 Multifocal lage masses Close contact with chest wall Probable nipple involvement Skin;nl LN;N2 BCS is not an appropriate suggestion Response to treatment MR imaging findings are a stronger predictor of pathologic response to NACT than clinical assessment It is more accurate in HER 2 + tumors and triple – But it’s not optimal Why ? Since MR imaging relies on contrast enhancement to depict residual disease, it may not depict small foci or scattered cancer cells or clusters that need little vascular supply to survive. Mixed fibrosis and scattered cancer cells are problem The limitation of MRI Depicting scattered residual disease is the major reason for the false-negative diagnoses. Also, this limitation is the source of high discrepancy in the tumor size measured at MR imaging and that measured at pathologic examination. Enhancing DCIS plus invasive tumor Better results The more aggressive tumors are known to have a better response to chemotherapy, and that would minimize the possibility of a false-negative diagnosis made at MR imaging. Diagnostic results of MR imaging should be used with caution in surgical planning: HER2-negative Hormone receptor–positive cancers Non masslike enhancement As they are more likely to show residual disease as small foci or scattered cells after NAC, leading to underestimation of residual disease extent at MR imaging Case 3 Case 4 Thanks for your attention